Indication
Morphea
Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues. Read more about Morphea
1 drugs 1 manufacturers
Drugs that treat it
Common Morphea therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMorphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues.
The disease most commonly affects children and middle-aged adults, with a marked predilection for females.
Clinically, active lesions present as erythematous or violaceous inflammatory plaques that gradually progress to indurated, ivory-white, or hyperpigmented sclerotic areas with tissue atrophy.
While it typically spares internal organs and lacks the systemic vasculopathy of systemic sclerosis, deeper involvement of subcutaneous fat, fascia, muscle, or bone can lead to joint contractures, limb asymmetry, and functional impairment.
- nih.gov
Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues Clinically, active lesions present as erythematous or violaceous inflammatory plaques that gradually progress to indurated, ivory-white, or hyperpigmented sclerotic areas with tissue atrophy While it typically spares internal organs and lacks the systemic vasculopathy of syste...
- nih.gov
Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues
- rheumatology.org
Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues Clinically, active lesions present as erythematous or violaceous inflammatory plaques that gradually progress to indurated, ivory-white, or hyperpigmented sclerotic areas with tissue atrophy While it typically spares internal organs and lacks the systemic vasculopathy of syste...
- mayoclinic.org
The disease most commonly affects children and middle-aged adults, with a marked predilection for females
- dermnetnz.org
The disease most commonly affects children and middle-aged adults, with a marked predilection for females While it typically spares internal organs and lacks the systemic vasculopathy of systemic sclerosis, deeper involvement of subcutaneous fat, fascia, muscle, or bone can lead to joint contractures, limb asymmetry, and functional impairment
- fairfaxderm.com
Clinically, active lesions present as erythematous or violaceous inflammatory plaques that gradually progress to indurated, ivory-white, or hyperpigmented sclerotic areas with tissue atrophy
Personalize your experience
Follow Morphea and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.